Navigation Links
KCAS Bioanalytical and Biomarker Services Welcomes Director of Large Molecule and Biomarker Services
Date:8/3/2017

KCAS Bioanalytical and Biomarker Services, a leading functional service contract research organization (CRO) is pleased to announce the expansion of their Large Molecule and Biomarker services team. Mr. Frank Spriggs joins KCAS as Director of Large Molecule and Biomarker Services.

Mr. Spriggs has more than 15 years involvement in Ligand Binding Assay (LBA) bioanalysis with a focus on pharmacokinetics, biomarkers, immunogenicity and quality assurance. His breath of knowledge in development and optimization of LBA methods will further strengthen KCAS’ development capability. “I am delighted Frank Spriggs has joined the growing KCAS team. Frank’s ligand binding assay expertise and product development experience positions KCAS to accelerate its growth and expansion of capabilities to serve our client’s development needs.” stated John Bucksath, CEO.

Mr. Spriggs joins KCAS from AIT Bioscience where he oversaw the LBA department and their molecular biology analytical techniques and services offered. Previously he worked for Pfizer and Amgen building upon his skills in method development, validation, and analysis of protein therapeutics in pre-clinical and clinical phases of drug development. He currently holds leadership roles within the Regualtory Sciences section of American Association of Pharmaceutical Scientist (AAPS). Spriggs earned his BS in Microbiology from Ohio University and an MS in Quality Assurance and Regulatory Affairs from Temple University.

“I am excited to be joining KCAS. The investment being made in the large molecule services has positioned KCAS to become the bioanalytical partner of choice in the ever expanding discipline of large molecule drug development.” stated Frank Spriggs.

About KCAS
KCAS Bioanalytical & Biomarker Services is a contract laboratory with 38+ years of bioanalytical expertise. Centrally located in Kansas City, KCAS provides small- and large-molecule PK, immunogenicity, and biomarker analysis operating a variety of equipment platforms to service a wide range of therapeutic areas. KCAS’ team leverages a highly scientific staff with an average tenure of 14 years at the company to provide clients of all sizes with expertise in robust assay development, validation, and sample analysis under fit-for-purpose Non-GLP, GLP, and GCP conditions for discovery, preclinical and clinical studies. Our teams have developed and validated more than 5,500 bioanalytical assays and have undergone 16 FDA inspections. Learn more at: http://www.kcasbio.com

Read the full story at http://www.prweb.com/releases/2017/07/prweb14555865.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. KCAS Bioanalytical and Biomarker Services Now Offers Ultra-Sensitive Validated Assay for Nicotine Studies
2. WuXi AppTec Lab Testing Divisions Bioanalytical Service Unit Passed FDA Inspection
3. KCAS Bioanalytical and Biomarker Services Announces Hire of Vice President of Marketing and Sales
4. KCAS Bioanalytical and Biomarker Services Now Offers Qualified MSD V-PLEX Human Cytokine 30-plex Assay
5. Call for Papers for Pittcon 2017 Technical Program - Emphasis on Food Safety, Homeland Security, Bioanalytical Science and Nano-imaging
6. KCAS Bioanalytical and Biomarker Services Appoints John Bucksath as New CEO
7. Frontage Bioanalytical Labs go Paperless With IDBS E-WorkBook 10
8. KCAS Bioanalytical and Biomarker Services Appoints Dr. Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis
9. Pittcon Announces Technical Program for 2016 - Hot Topics Include Food Safety, Homeland Security and Bioanalytical Science
10. Biotrial Bioanalytical Services (BBS) Proves Top-Quality Performance by Successfully Passing Another FDA Inspection
11. Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
(Date:10/9/2017)... Jupiter, FL (PRWEB) , ... October 09, 2017 , ... ... episode, scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on ... Agriculture industry is faced with the challenge of how to continue to feed a ...
Breaking Biology Technology:
(Date:7/20/2017)... 2017 Delta (NYSE: DAL ) customers now can ... at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan ... Delta,s biometric boarding pass experience that ... now integrated into the boarding process to allow eligible Delta SkyMiles Members ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
Breaking Biology News(10 mins):